HR 7346 United States House · 117th Congress

John W. Walsh Alpha-1 Home Infusion Act of 2022

Summary

John W. Walsh Alpha-1 Home Infusion Act of 2022 This bill provides for Medicare coverage of treatment for alpha-1 antitrypsin (AAT) deficiency (a protein deficiency that raises the risk of lung and other diseases). Specifically, the bill provides for coverage of at-home augmentation therapy for beneficiaries with emphysema as a result of severe hereditary AAT deficiency. Treatment must be provided through qualified home infusion therapy suppliers; beneficiaries must be under the care of a physician, nurse practitioner, or physician assistant.

Bill status in committee 1 of 4 stages cleared

Introduction

Mar 2022

Committee Review

Floor Vote

President

Introduced Mar 31, 2022 Last action Apr 1, 2022

Floor votes

How they voted

No floor votes recorded yet.

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Apr 1, 2022

Committee

Referred to the Subcommittee on Health.

lower

Mar 31, 2022

Committee

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

lower

Mar 31, 2022

Introduced

Introduced in House

lower

1 primary · 15 co-sponsors